Omnicell Inc

Omnicell Inc Stock Forecast & Price Prediction

Live Omnicell Inc Stock (OMCL) Price
$28.58

4

Ratings

  • Buy 2
  • Hold 1
  • Sell 1
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price

$28.58

P/E Ratio

P/E Ratio not available for OMCL

Volume Traded Today

$567,500

Dividend

Dividends not available for OMCL

52 Week High/low

77.14/26.66

Omnicell Inc Market Cap

$1.30B

🛑 Alert: These ten stocks could have higher potential than $OMCL 🛑

Before you buy OMCL you’ll want to see this list of ten stocks that have huge potential. Want to see if OMCL made the cut? Enter your email below

OMCL Summary

Based on ratings from 4 stock analysts, the Omnicell Inc stock price is expected to increase by 18.96% in 12 months. This is calculated by using the average 12-month stock price forecast for Omnicell Inc. The lowest target is $26.00 and the highest is $39.00. Please note analyst price targets are not guaranteed and could be missed completely.

OMCL Analyst Ratings

OMCL is a stock in Technology which has been forecasted to be worth $34.00 as an average. On the higher end, the forecast price is $39.00 USD by jessica tassan from Piper Sandler and on the lower end OMCL is forecasted to be $26.00 by stan berenshteyn from Wells Fargo.

OMCL stock forecast by analyst

Analyst/Firm

Rating

Price Target

Change

Date

bill sutherland
Benchmark Co.

Buy

$38.0

maintained

Feb 9, 2024
stan berenshteyn
Wells Fargo

Hold

$26.0

maintained

Feb 9, 2024
allen lutz
Bank of America Securities

Buy

$38.0

reiterated

Feb 8, 2024
stephanie davis
Barclays

Sell

$33.0

initiatedcoverage

Jan 2, 2024
jessica tassan
Piper Sandler

Buy

$39.0

rated

Nov 29, 2023
anne samuel
J.P. Morgan

Hold

$28.0

maintained

Nov 6, 2023
matt hewitt
Craig-Hallum

Buy

$50.0

maintained

Nov 3, 2023
scott schoenhaus
KeyBanc

Hold

None

reiterated

Nov 3, 2023
david larsen
BTIG

Hold

None

downgraded

Nov 2, 2023
whit mayo
SVB Securities

Hold

$58.0

rated

Mar 29, 2023
sean wieland
Piper Sandler

Buy

$66.0

maintained

Feb 22, 2023
joy zhang cfa
SVB Securities

Hold

$54.0

reiterated

Dec 15, 2022
dev weerasuriya
Berenberg Bank

Buy

$73.0

maintained

Dec 14, 2022
iris long
Berenberg Bank

Hold

None

rated

Dec 13, 2021
steven halper
Cantor Fitzgerald

Hold

$155.0

maintained

Nov 2, 2021
eugene mannheimer
Colliers Securities

Buy

$164.0

reiterated

Jul 29, 2021
jamie stockton
Wells Fargo

Hold

$84.0

maintained

Oct 28, 2020
mitra ramgopal
Sidoti

Hold

$82.0

maintained

Oct 25, 2019
charles rhyee
Cowen & Co.

Hold

$29.0

maintained

Oct 30, 2015
steven crowley
Craig-Hallum

Hold

None

downgraded

Nov 1, 2013

OMCL Company Information

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.

OMCL
Omnicell Inc (OMCL)

When did it IPO

2001

Staff Count

3,890

Country

United States

Sector/Industry

Healthcare/Health Information Services

CEO

Mr. Randall A. Lipps

Market Cap

$1.30B

Omnicell Inc(OMCL) Financial Data

In 2023, OMCL generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that OMCL's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2019

N/A

Revenue From 2020

N/A

0.00 %
From Previous Year

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year
  • Revenue TTM $1.15B
  • Operating Margin TTM -0.08%
  • Gross profit TTM $589.0M
  • Return on assets TTM -0.01%
  • Return on equity TTM -0.02%
  • Profit margin -0.017760001%
  • Book value 26.13%
  • Market capitalisation $1.30B
  • Revenue for 2020 N/A
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • EPS this year -0.45
  • EPS next year N/A

Omnicell Inc(OMCL) Latest News

... ...

Similar Stocks to Omnicell Inc OMCL

🛑 Alert: These ten stocks could have higher potential than $OMCL 🛑

Before you buy OMCL you’ll want to see this list of ten stocks that have huge potential. Want to see if OMCL made the cut? Enter your email below

...

OMCL Frequently asked questions

The highest forecasted price for OMCL is $39.00 from jessica tassan at Piper Sandler.

The lowest forecasted price for OMCL is $26.00 from stan berenshteyn from Wells Fargo

The OMCL analyst ratings consensus are 2 buy ratings, 1 hold ratings, and 1 sell ratings.